[Federal Register: September 8, 1999 (Volume 64, Number 173)]
[Notices]               
[Page 48841]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08se99-73]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Clinical Laboratory Improvement Advisory Committee (CLIAC) 
Meeting: Correction

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announced the following committee meeting in the 
Federal Register on August 23, 1999, Volume 64, Number 162, Page 45971.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Times and Dates: 8:30 a.m.-5 p.m., September 22, 1999. 8:30 
a.m.-3:30 p.m., September 23, 1999.
    Correction: Please note, ``potential rulemaking for genetic 
testing'' should be added to the previously published agenda.
    Contact Person for Additional Information: John C. Ridderhof, 
Dr.P.H., Division of Laboratory Systems, Public Health Practice 
Program Office, CDC, 4770 Buford Highway, NE, M/S G-25, Atlanta, 
Georgia 30341-3724, telephone 770/488-8076, FAX 770/488-8282.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining 
to announcements of meetings and other committee management 
activities, for the both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 99-23382 Filed 9-3-99; 10:00 am]
BILLING CODE 4163-18-P